Getz G, Höfling H, Mesirov JP, et al. Comment on "The consensus coding sequences of human breast and colorectal cancers". Science. 2007;317(5844):1500. doi:10.1126/science.1138764
Li N, Yousefi M, Nakauka-Ddamba A, et al. The Msi Family of RNA-Binding Proteins Function Redundantly as Intestinal Oncoproteins. Cell Rep. 2015;13(11):2440-55. doi:10.1016/j.celrep.2015.11.022
Garraway LA. Concordance and discordance in tumor genomic profiling. J Clin Oncol. 2012;30(24):2937-9. doi:10.1200/JCO.2011.41.3138
Cho J, Bass AJ, Lawrence MS, et al. Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximab. Mol Cancer. 2014;13:141. doi:10.1186/1476-4598-13-141
Konieczkowski DJ, Garraway LA. Resistance to EGFR blockade in colorectal cancer: liquid biopsies and latent subclones. Cell Res. 2013;23(1):13-4. doi:10.1038/cr.2012.115
Waldron L, Ogino S, Hoshida Y, et al. Expression profiling of archival tumors for long-term health studies. Clin Cancer Res. 2012;18(22):6136-46. doi:10.1158/1078-0432.CCR-12-1915
Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14(2):207-15. doi:10.1016/j.chom.2013.07.007
Hanna MC, Go C, Roden C, et al. Colorectal cancers from distinct ancestral populations show variations in BRAF mutation frequency. PLoS One. 2013;8(9):e74950. doi:10.1371/journal.pone.0074950
Nan H, Morikawa T, Suuriniemi M, et al. Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations. J Natl Cancer Inst. 2013;105(24):1852-61. doi:10.1093/jnci/djt331
Sears CL, Garrett WS. Microbes, microbiota, and colon cancer. Cell Host Microbe. 2014;15(3):317-28. doi:10.1016/j.chom.2014.02.007